|
🐜
|
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
15 auth.
T. Pearson,
G. Mensah,
R. W. Alexander,
Jeffrey L. Anderson,
R. Cannon,
M. Criqui,
Y. Fadl,
S. Fortmann,
Yuling Hong,
G. Myers,
...
N. Rifai,
Sidney C. Smith,
K. Taubert,
Russell P. Tracy,
F. Vinicor
|
12 |
2003 |
12
🐜
|
|
🦁
|
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.
11 auth.
G. Myers,
W. Miller,
J. Coresh,
J. Fleming,
N. Greenberg,
T. Greene,
...
T. Hostetter,
A. Levey,
M. Panteghini,
M. Welch,
J. Eckfeldt
|
10 |
2006 |
10
🦁
|
|
🦁
|
The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.
G. Myers,
Cooper Gr,
Winn Cl,
S. Sj
|
8 |
1989 |
8
🦁
|
|
🐬
|
The national glycohemoglobin standardization program: a five-year progress report.
R. Little,
C. Rohlfing,
H. Wiedmeyer,
G. Myers,
D. Sacks,
D. Goldstein
|
8 |
2001 |
8
🐬
|
|
🐜
|
Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures.
17 auth.
W. Miller,
G. Myers,
I. Sakurabayashi,
L. Bachmann,
S. Caudill,
Andrzej Dziekoński,
Selvin H Edwards,
M. M. Kimberly,
W. Korzun,
E. Leary,
...
K. Nakajima,
Masakazu Nakamura,
G. Nilsson,
R. Shamburek,
G. Vetrovec,
G. Warnick,
A. Remaley
|
8 |
2010 |
8
🐜
|
|
🐜
|
Creatinine measurement: state of the art in accuracy and interlaboratory harmonization.
7 auth.
W. Miller,
G. Myers,
E. Ashwood,
A. Killeen,
E. Wang,
L. Thienpont,
...
L. Siekmann
|
8 |
2005 |
8
🐜
|
|
🐜
|
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.
13 auth.
K. Mayer,
M. Dubé,
D. Sprecher,
W. K. Henry,
J. Aberg,
F. Torriani,
H. Hodis,
J. Schouten,
Jules Levin,
G. Myers,
...
R. Zackin,
T. Nevin,
J. Currier
|
7 |
2000 |
7
🐜
|
|
🐢
|
Distribution and correlates of C-reactive protein concentrations among adult US women.
E. Ford,
W. Giles,
A. Mokdad,
G. Myers
|
7 |
2004 |
7
🐢
|
|
🦁
|
Practice Guidelines : Emerging Biomarkers for Primary Prevention of Cardiovascular Disease
11 auth.
G. Myers,
R. Christenson,
M. Cushman,
C. Ballantyne,
G. Cooper,
C. Pfeiffer,
...
S. Grundy,
D. Labarthe,
D. Levy,
N. Rifai,
P. Wilson
|
7 |
2009 |
7
🦁
|
|
🦁
|
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Report From the Laboratory Science Discussion Group
15 auth.
G. Myers,
N. Rifai,
R. Tracy,
W. Roberts,
R. Alexander,
L. Biasucci,
J. Catravas,
T. Cole,
G. Cooper,
B. Khan,
...
M. M. Kimberly,
E. Stein,
K. Taubert,
G. Warnick,
P. Waymack
|
7 |
2004 |
7
🦁
|
|
🦁
|
Why commutability matters.
G. Myers,
R. Rej
|
7 |
2006 |
7
🦁
|
|
🐬
|
C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000.
E. Ford,
W. Giles,
G. Myers,
N. Rifai,
P. Ridker,
D. Mannino
|
7 |
2003 |
7
🐬
|
|
🐢
|
Reference materials and commutability.
H. Vesper,
W. G. Miller,
G. Myers
|
7 |
2007 |
7
🐢
|
